ECSP045096A - Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1" - Google Patents
Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1"Info
- Publication number
- ECSP045096A ECSP045096A EC2004005096A ECSP045096A ECSP045096A EC SP045096 A ECSP045096 A EC SP045096A EC 2004005096 A EC2004005096 A EC 2004005096A EC SP045096 A ECSP045096 A EC SP045096A EC SP045096 A ECSP045096 A EC SP045096A
- Authority
- EC
- Ecuador
- Prior art keywords
- heteroarilo
- nociceptin
- orl
- derivatives
- receiver
- Prior art date
Links
- 102000048266 Nociceptin Human genes 0.000 title 1
- 108090000622 Nociceptin Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- PULGYDLMFSFVBL-SMFNREODSA-N nociceptin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)[C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 PULGYDLMFSFVBL-SMFNREODSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 208000007848 Alcoholism Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 201000007930 alcohol dependence Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Se describen novedosos compuestos de la fórmula en la cual R es heteroarilo optativamente sustituido ó R1 es H ó alquilo C1-C6 YR2 y R3 son -CH3, -OCH3 ó halo;ó una sal ó solvato farmacéuticamente aceptable de los mismos, composiciones farmacéuticas elaboradas con los mismos y el uso de dichos compuestos en el tratamiento del dolor, la ansiedad, la tos, el asma, la depresión y el alcoholismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33328401P | 2001-11-07 | 2001-11-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP045096A true ECSP045096A (es) | 2004-06-28 |
Family
ID=23302135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2004005096A ECSP045096A (es) | 2001-11-07 | 2004-05-06 | Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1" |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6727254B2 (es) |
| EP (1) | EP1442036B1 (es) |
| JP (2) | JP4246066B2 (es) |
| KR (1) | KR100596261B1 (es) |
| CN (1) | CN1252068C (es) |
| AR (1) | AR037211A1 (es) |
| AT (1) | ATE315566T1 (es) |
| BR (1) | BR0213907A (es) |
| CA (1) | CA2465871C (es) |
| CY (1) | CY1105208T1 (es) |
| DE (1) | DE60208724T2 (es) |
| DK (1) | DK1442036T3 (es) |
| EC (1) | ECSP045096A (es) |
| ES (1) | ES2256590T3 (es) |
| HU (1) | HUP0402329A2 (es) |
| IL (2) | IL161120A0 (es) |
| MX (1) | MXPA04004276A (es) |
| MY (1) | MY126268A (es) |
| NO (1) | NO329026B1 (es) |
| NZ (1) | NZ532088A (es) |
| PE (1) | PE20030719A1 (es) |
| PL (1) | PL370269A1 (es) |
| RU (1) | RU2327698C2 (es) |
| TW (1) | TWI317360B (es) |
| WO (1) | WO2003039469A2 (es) |
| ZA (1) | ZA200403404B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| US20040067950A1 (en) * | 1998-07-27 | 2004-04-08 | Schering-Plough Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| EP1567497B1 (en) * | 2002-12-06 | 2009-09-23 | Purdue Research Foundation | Pyridines for treating injured mammalian nerve tissue |
| US8729107B2 (en) * | 2002-12-06 | 2014-05-20 | Purdue Research Foundation | Pyridines for treating injured mammalian nerve tissue |
| WO2005089761A1 (en) * | 2004-03-17 | 2005-09-29 | Pfizer Limited | Combination for treating inflammatory diseases |
| MX2007003061A (es) * | 2004-09-15 | 2007-05-21 | Schering Plough Ltd | Procedimiento para la preparacion de 8-azabiciclo[3.2.1]octan-3- oles sustituidos. |
| DE102005016460A1 (de) | 2005-04-11 | 2006-10-19 | Grünenthal GmbH | Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit |
| PE20071159A1 (es) | 2005-10-31 | 2007-11-30 | Schering Corp | Derivados de tropano 3-monosustituido como ligandos de receptores de nociceptina |
| DE102006046745A1 (de) * | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
| KR101333660B1 (ko) * | 2008-07-21 | 2013-11-27 | 시오노기세이야쿠가부시키가이샤 | 치환-퀴녹살린-형 가교-피페리딘 화합물 및 그의 용도 |
| GB201004311D0 (en) | 2010-03-15 | 2010-04-28 | Proximagen Ltd | New enzyme inhibitor compounds |
| GB201115853D0 (en) | 2011-09-14 | 2011-10-26 | Proximagen Ltd | New enzyme inhibitor compounds |
| US9724340B2 (en) * | 2015-07-31 | 2017-08-08 | Attenua, Inc. | Antitussive compositions and methods |
| WO2025085818A1 (en) * | 2023-10-19 | 2025-04-24 | Purdue Pharma L.P. | Sunobinop for use in method of treating alcohol use disorder |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352707A (en) | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
| US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| TW590268U (en) * | 2000-08-08 | 2004-06-01 | Wistron Corp | Heat dissipating device |
-
2002
- 2002-11-05 MY MYPI20024131A patent/MY126268A/en unknown
- 2002-11-05 TW TW091132573A patent/TWI317360B/zh not_active IP Right Cessation
- 2002-11-05 AR ARP020104215A patent/AR037211A1/es unknown
- 2002-11-05 PE PE2002001078A patent/PE20030719A1/es not_active Application Discontinuation
- 2002-11-06 CN CNB028220226A patent/CN1252068C/zh not_active Expired - Fee Related
- 2002-11-06 MX MXPA04004276A patent/MXPA04004276A/es active IP Right Grant
- 2002-11-06 EP EP02802860A patent/EP1442036B1/en not_active Expired - Lifetime
- 2002-11-06 ES ES02802860T patent/ES2256590T3/es not_active Expired - Lifetime
- 2002-11-06 PL PL02370269A patent/PL370269A1/xx unknown
- 2002-11-06 WO PCT/US2002/035539 patent/WO2003039469A2/en not_active Ceased
- 2002-11-06 CA CA002465871A patent/CA2465871C/en not_active Expired - Fee Related
- 2002-11-06 DE DE60208724T patent/DE60208724T2/de not_active Expired - Lifetime
- 2002-11-06 RU RU2004117542/04A patent/RU2327698C2/ru not_active IP Right Cessation
- 2002-11-06 NZ NZ532088A patent/NZ532088A/en not_active IP Right Cessation
- 2002-11-06 KR KR1020047006246A patent/KR100596261B1/ko not_active Expired - Fee Related
- 2002-11-06 IL IL16112002A patent/IL161120A0/xx unknown
- 2002-11-06 US US10/288,976 patent/US6727254B2/en not_active Expired - Fee Related
- 2002-11-06 DK DK02802860T patent/DK1442036T3/da active
- 2002-11-06 HU HU0402329A patent/HUP0402329A2/hu unknown
- 2002-11-06 JP JP2003541761A patent/JP4246066B2/ja not_active Expired - Fee Related
- 2002-11-06 AT AT02802860T patent/ATE315566T1/de active
- 2002-11-06 BR BR0213907-3A patent/BR0213907A/pt not_active Application Discontinuation
-
2004
- 2004-03-28 IL IL161120A patent/IL161120A/en not_active IP Right Cessation
- 2004-05-05 ZA ZA200403404A patent/ZA200403404B/en unknown
- 2004-05-06 EC EC2004005096A patent/ECSP045096A/es unknown
- 2004-06-04 NO NO20042294A patent/NO329026B1/no not_active IP Right Cessation
-
2006
- 2006-04-07 CY CY20061100498T patent/CY1105208T1/el unknown
-
2008
- 2008-08-14 JP JP2008209104A patent/JP2009035556A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP045096A (es) | Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1" | |
| ME00555A (en) | Tryasolyl tropane derivatives as ccr5 modulators | |
| AR068413A2 (es) | Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia | |
| BG107171A (bg) | Производни на пурин | |
| MY130803A (en) | New quinuclidine amide derivatives | |
| AR031930A1 (es) | Antagonistas de mch y su uso en el tratamiento de la obesidad | |
| ATE302775T1 (de) | Carbolinderivate | |
| AUPR213700A0 (en) | Antiviral agents | |
| MXPA05011710A (es) | Derivados de pirimidina con actividad de crf. | |
| HK1042236A1 (zh) | 用於治療咳嗽的痛啡肽(nociceptin)受體orl-1激動劑 | |
| EA200201179A1 (ru) | Производные 2-аминокарбонил-9h-пурина | |
| PT1263725E (pt) | Novos compostos | |
| PL361361A1 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
| ATE346067T1 (de) | Carbolinderivate | |
| PT1399436E (pt) | Oxitocinas agonistas | |
| PL361282A1 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
| DE60214401D1 (de) | Hetero-bicyclische crf antagonisten | |
| IL174678A0 (en) | Arylindenophyridines and arylindenophyrimidines and their use as adenosine a2a receptor antagonist | |
| ATE406363T1 (de) | Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten | |
| AR010289A1 (es) | Derivados de piperidina, procedimiento para su preparacion, formulaciones farmaceuticas que contienen los derivados y su uso en el tratamiento dedesordenes psicoticos | |
| AR022797A1 (es) | Benzoil indoles n-sustituidos como agentes estrogenicos | |
| SE0301371D0 (sv) | New Compounds | |
| SE0403118D0 (sv) | New compounds 2 | |
| BR0112957A (pt) | Composto, método de tratamento, uso de um composto, e, composição farmacêutica | |
| PE20061037A1 (es) | Compuestos tetraciclicos como moduladores de los receptores de glucocorticoides |